Skip to main content
VREOF
OTC Life Sciences

Vireo Growth Acquires Key NY Cannabis Facility for $88.5M, Secures $90M in Debt

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Healthcare
Sentiment info
Neutral
Importance info
8
Price
$0.43
Mkt Cap
$503.457M
52W Low
$0.323
52W High
$0.8
52W Position info
33% above low
Off High info
46% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

VREOF sits 33% above its 52-week low of $0.323.

Summary

Vireo Growth Inc. has acquired its 389,000 square foot cannabis cultivation and production facility in Perth, New York, for $88.5 million, funding the purchase with $90 million in new debt.


Key Events · M&A and Partnerships · VREOF

  • Acquisition of Key Facility

    Vireo's subsidiary acquired a 389,000 sq ft cannabis cultivation and production facility in Perth, NY, for $88.5 million by exercising a purchase option. This facility was previously leased by the company.

  • Significant Debt Incurred

    The acquisition was financed through a $49 million seller-financed note at 15% interest (due May 2027, extendable) and a $41 million loan from Chicago Atlantic at prime plus 5.75% (due May 2028), totaling $90 million in new debt.

  • Strategic Asset Ownership

    The company now owns a critical operational asset previously leased, enhancing control over its cannabis cultivation and production capabilities.

  • Continued Growth Strategy

    This acquisition is consistent with Vireo's recent pattern of strategic expansions and strong financial performance, as highlighted in recent earnings reports and prior acquisition announcements.


Analysis · VREOF · Life Sciences

This acquisition of a previously leased, critical operational asset solidifies Vireo Growth's control over its supply chain and aligns with its aggressive growth strategy through strategic acquisitions. While the $88.5 million purchase price and the associated $90 million in new debt, including a $49 million note at a high 15% interest rate, introduce significant financial obligations, the move converts a lease expense into an owned asset. This follows a series of major acquisitions and strong financial results, indicating a continued expansion strategy.

How filings like this one have moved

In the 30 days to Nov 11, 2026, 48.1% of the 1752 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.29%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, VREOF was trading at $0.43 on OTC in the Life Sciences sector, with a market capitalization of approximately $503.5M. The 52-week trading range was $0.32 to $0.80. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

VREOF - Latest Insights

VREOF
Nov 10, 2026, 4:05 PM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $6.68
Real-time Price: $6.74 info
Change: +$0.060 (+0.90%) info
Market Cap: $347.702M info
VREOF
Nov 10, 2026, 7:30 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $6.78
Real-time Price: $6.74 info
Change: -$0.040 (-0.59%) info
Market Cap: $347.702M info
VREOF
Oct 30, 2026, 4:15 PM EDT
Filing Type: S-4/A
Importance Score:
7
Price at Filing: $7.35
Real-time Price: $6.74 info
Change: -$0.610 (-8%) info
Market Cap: $347.702M info
VREOF
Oct 09, 2026, 4:34 PM EDT
Filing Type: S-4
Importance Score:
8
Price at Filing: $9.38
Real-time Price: $6.74 info
Change: -$2.64 (-28%) info
Market Cap: $347.702M info
VREOF
Oct 08, 2026, 4:06 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $9.21
Real-time Price: $6.74 info
Change: -$2.47 (-27%) info
Market Cap: $347.702M info